Published in Mol Endocrinol on February 16, 2010
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect (2012) 3.17
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51
Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol (2010) 2.28
Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol (2011) 2.28
Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes (2010) 2.15
Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect (2013) 2.12
Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect (2011) 1.80
Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev (2014) 1.71
Predicting later-life outcomes of early-life exposures. Environ Health Perspect (2012) 1.67
Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect (2012) 1.63
The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes (2011) 1.49
Minireview: PPARγ as the target of obesogens. J Steroid Biochem Mol Biol (2011) 1.40
The retinoid X receptors and their ligands. Biochim Biophys Acta (2011) 1.32
Childhood obesity and environmental chemicals. Mt Sinai J Med (2011) 1.31
The obesogenic effect of high fructose exposure during early development. Nat Rev Endocrinol (2013) 1.23
The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. J Steroid Biochem Mol Biol (2011) 1.17
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta (2012) 1.13
Endocrine disruptors and obesity. Nat Rev Endocrinol (2015) 1.09
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol (2013) 1.07
Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Environ Health Perspect (2012) 1.07
Fetal programming of body composition, obesity, and metabolic function: the role of intrauterine stress and stress biology. J Nutr Metab (2012) 1.07
Obesogens, stem cells and the developmental programming of obesity. Int J Androl (2012) 1.05
Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev (2011) 1.02
Zebrafish obesogenic test: a tool for screening molecules that target adiposity. J Lipid Res (2011) 1.01
Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Environ Health Prev Med (2013) 0.97
Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells. Toxicol Sci (2011) 0.95
The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals. Endocrinology (2015) 0.94
The epigenetic lorax: gene-environment interactions in human health. Epigenomics (2012) 0.92
Adipocytes under assault: environmental disruption of adipose physiology. Biochim Biophys Acta (2013) 0.89
Halogenated bisphenol-A analogs act as obesogens in zebrafish larvae (Danio rerio). Toxicol Sci (2014) 0.88
Transcriptional and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the brominated flame retardant BDE-47. Environ Sci Technol (2014) 0.88
Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells. Toxicology (2015) 0.87
Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol (2014) 0.84
Obesogens: an emerging threat to public health. Am J Obstet Gynecol (2016) 0.83
Transgenerational effects of obesogens and the obesity epidemic. Curr Opin Pharmacol (2014) 0.82
What Are We Putting in Our Food That Is Making Us Fat? Food Additives, Contaminants, and Other Putative Contributors to Obesity. Curr Obes Rep (2014) 0.82
Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput Data. Environ Health Perspect (2016) 0.82
The endocrine disrupting chemical tolylfluanid alters adipocyte metabolism via glucocorticoid receptor activation. Mol Endocrinol (2013) 0.81
Obesogens, stem cells and the maternal programming of obesity. J Dev Orig Health Dis (2011) 0.80
Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content. FASEB J (2015) 0.80
Molecular analysis of endocrine disruption in hornyhead turbot at wastewater outfalls in southern california using a second generation multi-species microarray. PLoS One (2013) 0.80
Endocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway Analysis. J Cancer Prev (2015) 0.80
In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter. Toxicol Res (Camb) (2015) 0.79
Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol (2016) 0.78
The perfect storm for obesity. Obesity (Silver Spring) (2013) 0.78
Effects of Crude Oil/Dispersant Mixture and Dispersant Components on PPARγ Activity in Vitro and in Vivo: Identification of Dioctyl Sodium Sulfosuccinate (DOSS; CAS #577-11-7) as a Probable Obesogen. Environ Health Perspect (2015) 0.78
Association of placenta organotin concentrations with growth and ponderal index in 110 newborn boys from Finland during the first 18 months of life: a cohort study. Environ Health (2014) 0.78
The Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of Zebrafish. PLoS One (2015) 0.78
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis (2015) 0.78
Endocrine Disruptors and Obesity. Curr Obes Rep (2017) 0.77
Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells. Chem Res Toxicol (2015) 0.77
Editor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of Adipogenesis. Toxicol Sci (2016) 0.77
Tributyltin differentially promotes development of a phenotypically distinct adipocyte. Obesity (Silver Spring) (2015) 0.76
Adverse effects in adulthood resulting from low-level dioxin exposure in juvenile zebrafish. Endocr Disruptors (Austin) (2015) 0.76
Altered Adipogenesis in Zebrafish Larvae Following High Fat Diet and Chemical Exposure Is Visualised by Stimulated Raman Scattering Microscopy. Int J Mol Sci (2017) 0.75
Tributyltin increases the expression of apoptosis- and adipogenesis-related genes in rat ovaries. Clin Exp Reprod Med (2012) 0.75
Markers of Oxidative Stress in Human Milk do not Differ by Maternal BMI But are Related to Infant Growth Trajectories. Matern Child Health J (2017) 0.75
Effects of long-term endocrine disrupting compound exposure on Macaca mulatta embryonic stem cells. Reprod Toxicol (2016) 0.75
Monoethylhexyl Phthalate Elicits an Inflammatory Response in Adipocytes Characterized by Alterations in Lipid and Cytokine Pathways. Environ Health Perspect (2016) 0.75
PPARs and xenobiotic-induced adverse effects: relevance to human health. PPAR Res (2011) 0.75
Development of a Three-Dimensional Adipose Tissue Model for Studying Embryonic Exposures to Obesogenic Chemicals. Ann Biomed Eng (2016) 0.75
THE DIABETES EPIDEMIC: Environmental Chemical Exposure in Etiology and Treatment. San Franc Med (2012) 0.75
More fat, less bone? Flame retardant may deliver a one-two punch. Environ Health Perspect (2014) 0.75
Population Epigenetics. Curr Opin Syst Biol (2017) 0.75
Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates towards adipocyte lineage. Toxicol Appl Pharmacol (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
Environmental contributions to the obesity epidemic. Science (1998) 11.87
Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol (2006) 11.36
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (2007) 8.64
PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest (2004) 5.29
Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr (2005) 4.57
Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells (2007) 3.99
Retracted A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol (2007) 3.97
Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation (1996) 3.40
Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol (2005) 3.15
Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med (2002) 3.04
Developmental programming of obesity in mammals. Exp Physiol (2006) 2.85
Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol (2002) 2.73
Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology (2006) 2.56
Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol (2006) 2.41
Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest (2006) 2.40
Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci (2009) 2.35
Regulation of PPARgamma activity during adipogenesis. Int J Obes (Lond) (2005) 2.31
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 2.30
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med (2008) 2.14
Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) (2001) 2.07
Bone stem cells. J Cell Biochem Suppl (1998) 2.02
Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord (2007) 1.96
Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol (1996) 1.90
Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol (2007) 1.84
Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res (2003) 1.68
Animal models and programming of the metabolic syndrome. Br Med Bull (2001) 1.64
Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway. Mol Pharmacol (2004) 1.58
Endocrine disruptors and the obesity epidemic. Toxicol Sci (2003) 1.57
Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest (2007) 1.52
FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng (2006) 1.50
Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone (2008) 1.30
Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes (Lond) (2008) 1.21
Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol (2007) 1.19
Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol (2004) 1.16
A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis. J Biol Chem (2008) 1.16
Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol (2000) 1.15
The role of physical activity in the prevention and management of obesity. J Am Diet Assoc (1998) 1.13
Early life exposure to environmental levels of the aromatase inhibitor tributyltin causes masculinisation and irreversible sperm damage in zebrafish (Danio rerio). Aquat Toxicol (2003) 1.10
Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol Pharmacol (1994) 1.10
Developmental programming and adult obesity: the role of leptin. Curr Opin Endocrinol Diabetes Obes (2007) 1.09
Fetal and neonatal pathways to obesity. Front Horm Res (2008) 1.08
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest (2007) 1.07
Early nutrition: impact on epigenetics. Forum Nutr (2007) 1.07
Tributyltin causes masculinization in fish. Environ Toxicol Chem (2003) 1.02
Function of pref-1 as an inhibitor of adipocyte differentiation. Int J Obes Relat Metab Disord (2000) 0.96
Fetal and infant origins of cardiovascular disease. Arch Dis Child (1993) 0.95
Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products. Environ Pollut (1999) 0.95
The Roles of PPARs in the Fetal Origins of Metabolic Health and Disease. PPAR Res (2008) 0.93
A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Mol Endocrinol (1999) 0.93
TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology (2008) 0.93
Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity. Birth Defects Res C Embryo Today (2005) 0.92
Butyltin compounds in human liver. Environ Res (2002) 0.91
Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome. J Gastrointestin Liver Dis (2008) 0.91
The fat tail of obesity as told by the genome. Curr Opin Clin Nutr Metab Care (2008) 0.88
The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations. BMC Dev Biol (2008) 0.88
Two-generation reproductive toxicity study of tributyltin chloride in female rats. J Toxicol Environ Health A (2001) 0.87
Triphenyltin as a potential human endocrine disruptor. J Toxicol Environ Health B Crit Rev (2004) 0.85
Mechanisms of imposex induction in the mud snail, Ilyanassa obsoleta: TBT as a neurotoxin and aromatase inhibitor. Mar Environ Res (2002) 0.84
Butyltin compounds in river otters (Lutra canadensis) from the northwestern United States. Arch Environ Contam Toxicol (1999) 0.81
[Potential of chondrogenesis of bone marrow stromal cells co-cultured with chondrocytes on biodegradable scaffold: in vivo experiment with pigs and mice]. Zhonghua Yi Xue Za Zhi (2007) 0.80
Daily intakes of tributyltin and triphenyltin compounds from meals. J AOAC Int (1995) 0.79
The genome of the Western clawed frog Xenopus tropicalis. Science (2010) 4.70
The dynamic genome of Hydra. Nature (2010) 4.00
Endocrine disrupters as obesogens. Mol Cell Endocrinol (2009) 2.80
Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology (2006) 2.56
Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol (2006) 2.41
Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest (2006) 2.28
Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol (2011) 2.28
Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Environ Health Perspect (2004) 2.16
Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect (2013) 2.12
Clinical features and management issues in Mowat-Wilson syndrome. Am J Med Genet A (2006) 1.97
Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord (2007) 1.96
Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest (2006) 1.75
Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem (2003) 1.69
Predicting later-life outcomes of early-life exposures. Environ Health Perspect (2012) 1.67
Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect (2012) 1.63
New modes of action for endocrine-disrupting chemicals. Mol Endocrinol (2005) 1.54
Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today (2011) 1.52
The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol (2006) 1.47
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors. Environ Health (2013) 1.42
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal (2009) 1.41
Minireview: PPARγ as the target of obesogens. J Steroid Biochem Mol Biol (2011) 1.40
Minireview: the case for obesogens. Mol Endocrinol (2009) 1.33
Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem (2006) 1.33
Learning from and about others: towards using imitation to bootstrap the social understanding of others by robots. Artif Life (2005) 1.28
Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res (2006) 1.26
The obesogenic effect of high fructose exposure during early development. Nat Rev Endocrinol (2013) 1.23
The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. J Steroid Biochem Mol Biol (2011) 1.17
Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol (2005) 1.15
Benzoate X receptors alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors. J Biol Chem (2002) 1.11
Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes. Drug Metab Dispos (2004) 1.09
Active repression by unliganded retinoid receptors in development: less is sometimes more. J Cell Biol (2003) 1.08
Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Environ Health Perspect (2012) 1.07
Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer (2009) 1.02
Characterizing genetic variants for clinical action. Am J Med Genet C Semin Med Genet (2014) 1.02
Multiple points of interaction between retinoic acid and FGF signaling during embryonic axis formation. Development (2004) 0.99
Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab (2015) 0.99
Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer (2007) 0.96
Activation of steroid and xenobiotic receptor (SXR, NR1I2) and its orthologs in laboratory, toxicologic, and genome model species. Environ Health Perspect (2008) 0.95
Designing green oxidation catalysts for purifying environmental waters. J Am Chem Soc (2010) 0.93
Transcriptional and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the brominated flame retardant BDE-47. Environ Sci Technol (2014) 0.88
Global analysis of RAR-responsive genes in the Xenopus neurula using cDNA microarrays. Dev Dyn (2005) 0.88
How do women of diverse backgrounds value prenatal testing outcomes? Prenat Diagn (2004) 0.88
Nutrition can modulate the toxicity of environmental pollutants: implications in risk assessment and human health. Environ Health Perspect (2012) 0.88
Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway. J Clin Immunol (2004) 0.86
Overlapping gene structure of human VLCAD and DLG4. Gene (2003) 0.86
Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity Epidemic. Environ Health Perspect (2016) 0.86
Retinoic acid signaling and neuronal differentiation. Cell Mol Life Sci (2015) 0.85
On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens. Environ Health Perspect (2016) 0.84
Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer. Prostate (2007) 0.84
Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation. J Biol Chem (2013) 0.83
Endocrine disrupting chemicals. J Steroid Biochem Mol Biol (2011) 0.83
Transgenerational effects of obesogens and the obesity epidemic. Curr Opin Pharmacol (2014) 0.82
B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR. Mol Endocrinol (2011) 0.81
Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption. J Endocrinol (2010) 0.80
RIPPLY3 is a retinoic acid-inducible repressor required for setting the borders of the pre-placodal ectoderm. Development (2012) 0.80
ERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis. Development (2013) 0.80
Development of humanized steroid and xenobiotic receptor mouse by homologous knock-in of the human steroid and xenobiotic receptor ligand binding domain sequence. J Toxicol Sci (2012) 0.79
Identification of novel nuclear hormone receptor ligands by activity-guided purification. Methods Enzymol (2003) 0.78
The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver. Mol Endocrinol (2012) 0.77
In utero exposure to benzo[a]pyrene increases adiposity and causes hepatic steatosis in female mice, and glutathione deficiency is protective. Toxicol Lett (2013) 0.76
Andrés Carrasco (1946-2014). Dev Biol (2014) 0.75
Reply to "Comment on 'On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens'". Environ Health Perspect (2017) 0.75
Oxidation of Ethidium using TAML Activators: A Model for High School Research Performed in Partnership with University Scientists. J Chem Educ (2013) 0.75
Brachydactylic multiple delta phalanges plus syndrome. Am J Med Genet A (2005) 0.75
Recovery mountain and the stages of change. Eat Disord (2002) 0.75
Looking at Graduate Medical Education Through a Different Lens: A Health Care System's Perspective. Acad Med (2015) 0.75